Looking at the stock we see that its previous close was $1.36 and the beta (5Y monthly) reads -0.288 with the day’s price range being $1.3301 – $1.3897. In terms of its 52-week price range, ATXI has a high of $15.00 and a low of $1.22. The company’s stock has lost about -28.42% over that past 30 days.
Avenue Therapeutics Inc has a market cap of $2.79 million and is expected to release its quarterly earnings report in March.
On the other hand, looking at the outlook for the ATXI stock, short term indicators assign the stock an average of 100% Sell, while medium term indicators assign it an average of 100% Sell.
Based on estimates by 1 analysts, where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 0 have rated the Avenue Therapeutics Inc (ATXI) stock as a Hold, while 1 rate it as a Buy. 0 analyst(s) rate it as overweight while 0 of them rated it as underweight, whereas 0 suggest the stock as a Sell. The stock has an overall rating of Buy and investors could take advantage and scoop up stock of the company.
Looking further, we note the current price level is -6.98% off its SMA20 and -20.00% from its 50-day simple moving average. The RSI (14) is pointing at 41.11 while the volatility over the past week is 5.67% and jumps to 10.00% over the past one month. The beta value is -0.31, while the average true range (ATR) is currently pointing at 0.14. The average price target for the stock over the next 12 months is $12, with the estimates having a low of $12 and a high of $12. These price ends are -782.35% and -782.35% off the current price level respectively, although investors could be excited at the prospect of a -782.35% if the ATXI share price touches on the median price of $12.
Coming back to Avenue Therapeutics Inc (NASDAQ:ATXI), we note that the average 3-month trading volume was 389.34K, while that of the preceding 10-day period stands at 79540.0. Current shares outstanding are 2.05 million.
The insiders hold 15.44% of the company’s shares while institutions hold 9.38%. The data shows that short shares as of 2025-01-31, stood at 0.15 million at a short ratio of 0.15. This represents a 754.00 short interest in shares outstanding on 2025-01-31. Shares short rose in January from the previous month at 22479.0. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock -32.00% down in year-to-date price movement.
